We are live on ! Find out more
IMI

Intermolecular, Inc.
IMI

Delisted

IMI was delisted on the 19th of September, 2019.

25 hedge funds and large institutions have $31.6M invested in Intermolecular, Inc. in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more capital invested

Capital invested by funds: $24M → $31.6M (+$7.61M)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

4% less funds holding

Funds holding: 2625 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
6
Reduced
6
Closed
5
Calls
Puts
Net Calls
Net Calls Change

IMI Hedge Fund Activity: Q2 2018 in Review

25 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q2 2018, worth a combined $31.6M — up 32% from $24M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of IMI and 4 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 6 added.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $1.19M. The largest seller was Barclays, exiting entirely with an estimated $490K sold.

  • 25 institutional investors held Intermolecular, Inc. (IMI) as of Q2 2018, down from 26 in Q1 2018.
  • Funds reported $31.6M of Intermolecular, Inc. stock for Q2 2018, up 32% quarter-over-quarter.
  • 4 funds opened new Intermolecular, Inc. positions in Q2 2018 and 5 closed out, a net change of -1 holder.
  • The largest Intermolecular, Inc. buyer in Q2 2018 was Wellington Management Group, an estimated $1.19M added.
  • The largest Intermolecular, Inc. seller in Q2 2018 was Barclays, an estimated $490K sold.

Based on aggregated 13F filings for Q2 2018.